Jason Chaffetz: The whistleblower complaint is only hearsay
Similar Posts
Weekly Update by Mark Armstrong – December 27, 2024
Greetings from Tyler, It’s already started. The mainstream is trying it’s level best to create some controversy about immigration. Trump has put Canada on notice, and I can’t help wondering how everybody’s feeling about it. I know Canadians are proud, but I’m pretty sure everywhere is going to be jealous. The whole world is seeing…
Weekly Update by Mark Armstrong – February 9, 2024
Greetings from Tyler, Someone demanded the pretender come front and center, and what he said is being discussed around the clock. It wasn’t the best move, considering that it reinforced what everybody knows. Maybe hiding wasn’t such a bad idea. His own Do J released a report saying that he was guilty of a crime…
- Breaking News | Iran | News
Iranian warship Alborz enters the Red Sea – Tasnim
DUBAI, Jan 1 (Reuters) – Iran’s Alborz warship has entered the Red Sea, the semi-official Tasnim news agency reported on Monday, at a time of soaring tensions on the key shipping route amid the Israel-Hamas war and attacks on vessels by forces allied to Tehran. Tasnim did not give details of the Alborz’s mission but…
Maduro’s ruling party win called ‘farce’ by Venezuelan opposition
May 26 (UPI) — Venezuela’s ruling party, led by President Nicolas Maduro, swept to victory in regional and parliamentary elections. The elections Sunday came as multiple opposition groups called for Venezuelans to boycott the vote in protest to last July’s presidential election in which Maduro was declared the winner in a disputed contest over Edmundo…
- Breaking News | China | News
South China Sea: Why the Philippines and China are on a collision course
Take a close look at a video of Sunday’s “collision” between a Philippine coastguard ship and a Chinese maritime militia vessel in the South China Sea. As the stern of one bumps the deck of the other, right in the middle of the frame is a Filipino television crew scrambling to get what in the…
Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders
LONDON — Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and rare blood types. Two patients in the U.K. received tiny doses — equivalent to a few teaspoons — of the…
